RP-HPLC vs mass spectrometry: how peptide purity and identity are verified

A certificate of analysis for a research peptide usually leads with two measurements: a purity figure from RP-HPLC and an identity confirmation from mass spectrometry. They are easy to read as a single claim — “99% pure” — but they answer different questions. Peptide purity testing asks how much of the material in the vial is one chemical species; identity testing asks whether that species is the molecule named on the label. Neither answer implies the other.

This guide explains what each technique actually measures, what its output looks like and — just as important — what it cannot see. It is written for researchers assessing a supplier's analytics rather than for chromatographers: the aim is that the QC section of a batch certificate should be fully readable, and its limits understood, before any research material is ordered.

Purity and identity are different questions

A sample can be 99% pure and be 99% of the wrong molecule. Chromatographic purity is a statement about homogeneity: it says that one species dominates the material, and quantifies by how much. It says nothing about which species that is. A synthesis that produced a truncated sequence, a peptide with the right residues in the wrong order, or a different compound altogether can still give a clean, single-peak chromatogram.

Identity data has the mirror-image weakness. A mass spectrum can show that a molecule of exactly the expected mass is present without saying how much of the sample it represents. Correct identity is compatible with poor purity, and high purity is compatible with wrong identity — which is why either number on its own is close to meaningless. A credible certificate reports both for the same batch; how to read a peptide certificate of analysis walks through the full document field by field.

How RP-HPLC measures peptide purity

Reversed-phase high-performance liquid chromatography (RP-HPLC) is the standard purity assay for synthetic peptides. The column is packed with silica particles bonded to hydrophobic alkyl chains, typically eighteen carbons long — the C18 column that appears on most peptide certificates. The dissolved sample is carried through this column by a mobile phase that starts aqueous and becomes steadily more organic: most commonly a water–acetonitrile gradient containing a small amount of trifluoroacetic acid (TFA) or a similar ion-pairing agent, which sharpens peak shape.

Peptides partition between the mobile phase and the C18 surface, so the column separates them by hydrophobicity — the more strongly a species interacts with the stationary phase, the later it elutes. At the outlet, a UV detector monitors absorbance at around 214–220 nm, the region where the peptide (amide) bond absorbs. Detecting the backbone itself means every peptide-related species registers, whether or not it contains aromatic residues.

The output is a chromatogram: absorbance plotted against retention time, with each resolved species appearing as a peak. Purity is calculated as the area of the main peak as a percentage of the total integrated peak area — the area per cent figure reported on a certificate as, for example, ≥99%. Because the deletion sequences and side-reaction products generated by solid-phase peptide synthesis usually differ slightly in hydrophobicity from the target, RP-HPLC resolves precisely the impurities a synthetic peptide is most likely to contain.

What RP-HPLC cannot tell you

Three limitations matter when reading an HPLC chromatogram purity figure:

• It does not identify the molecule. A retention time is not a fingerprint; a vast number of compounds could elute at the same point in the same gradient. The chromatogram shows that one species dominates — not which one.
• Co-eluting impurities hide under the main peak. An impurity whose hydrophobicity is close enough to the target's elutes with it and is integrated into the same peak, so any reported purity is bounded by the resolving power of the method used.
• It only sees what absorbs at the detection wavelength. Water, inorganic salts and counter-ions such as residual TFA give no peptide-bond signal, so they are simply absent from the calculation. This is why 99% chromatographic purity does not mean 99% peptide by mass — peptide purity vs net peptide content covers the distinction in detail.

How mass spectrometry confirms identity

A mass spectrometer measures the mass-to-charge ratio (m/z) of ionised molecules. For peptide identity work the usual method is electrospray ionisation (ESI): the dissolved sample is sprayed from a fine capillary held at high voltage, transferring intact molecular ions into the gas phase. Peptides readily accept more than one proton, so an ESI-MS peptide spectrum shows a series of multiply charged ions — [M+2H]²⁺, [M+3H]³⁺ and so on — which brings even large molecules into the analyser's m/z range. Software then deconvolutes the charge-state series into a single neutral molecular mass. MALDI-TOF, in which a laser desorbs the sample from a crystalline matrix and predominantly produces singly charged ions, is a common alternative for the same purpose.

Identity confirmation is then arithmetic. The molecular formula of the target fixes its theoretical mass, and the certificate compares the observed value against it. BPC-157, for example, has the molecular formula C₆₂H₉₈N₁₆O₂₂, which gives an average mass of about 1419.5 Da (monoisotopic, about 1418.7 Da); its doubly protonated ion is therefore expected near m/z 710.8. An observed mass matching the calculation within the instrument's tolerance confirms that the elemental composition of the main component is the one on the label.

What mass spectrometry cannot tell you

In this role, mass spectrometry is essentially qualitative. Peak heights in a spectrum depend on how readily each species ionises, and ionisation efficiency varies from molecule to molecule — so a clean-looking spectrum is not a purity percentage and should never be read as one.

Intact-mass measurement also has an inherent ambiguity: species with the same elemental composition have the same mass. Leucine and isoleucine are the classic isobaric pair — identical formula, identical mass — so a sequence in which one has replaced the other is invisible to an intact-mass check, as is a peptide built from the correct residues in the wrong order. Resolving those questions requires deeper structural methods such as tandem MS (MS/MS) fragmentation or amino-acid analysis. For routine verification of a catalogue peptide — or independent confirmation of sample identity by a laboratory re-assaying material it has received — an intact mass match is strong evidence of correct composition rather than absolute proof of correct sequence — which is exactly why it is paired with, not substituted for, a purity assay.

Why credible QC needs both

The two techniques fail in opposite directions, which is what makes the pairing work. RP-HPLC quantifies homogeneity but cannot name the molecule; ESI-MS names the molecule but cannot quantify homogeneity. Side by side, each covers most of what the other misses:

Together, chromatographic purity and mass-spectrometric identity are the credible minimum for research-grade peptide QC — one number without the other leaves the more important question unanswered. That is the standard to hold any supplier to, including us: NorthScientific does not currently publish independent third-party analysis for the material it holds, and says so rather than implying otherwise.

Materials referenced: BPC-157 · TB-500 · Ipamorelin · full catalogue